| Literature DB >> 12586602 |
W G Bradley1, R H Widen, A M Weiser, J J Powers, L B Fountain, P Punjwani, S M Lofgren, T Hadzic, R Klein, W H Green, A Tanaka.
Abstract
The production of dendritic cells, both in-vivo and in-vitro, has become the intense focus of research activities. Common to many of these production protocols is the use of cytokines, typically granulocyte-monocyte colony stimulating factor and either interleukin 4 or tumor necrosis factor alpha or a combination of all three. Herein, we report our findings that a proprietary pinecone extract is capable of in a dose-dependent manner, and in the absence of exogenous cytokines, the rapid differentiation from peripheral blood mononuclear cells of mature CD1a-negative dendritic cells. Copyright 2002 Elsevier Science B.V.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12586602 DOI: 10.1016/S1567-5769(02)00267-9
Source DB: PubMed Journal: Int Immunopharmacol ISSN: 1567-5769 Impact factor: 4.932